Spojené štáty - angličtina - NLM (National Library of Medicine)

terrain pharmaceuticals - betamethasone acetate (unii: ti05ao53l7) (betamethasone - unii:9842x06q6m), betamethasone sodium phosphate (unii: 7bk02scl3w) (betamethasone - unii:9842x06q6m) - betamethasone acetate 3 mg in 1 ml - when oral therapy is not feasible, the intramuscular use of betamethasone sodium phosphate and betamethasone acetate injectable suspension is indicated as follows: allergic states control of severe or incapacitating allergic conditions intractable to adequate trials of conventional treatment in asthma, atopic dermatitis, contact dermatitis, drug hypersensitivity reactions, perennial or seasonal allergic rhinitis, serum sickness, transfusion reactions. dermatologic diseases bullous dermatitis herpetiformis, exfoliative erythroderma, mycosis fungoides, pemphigus, severe erythema multiforme (stevens-johnson syndrome). endocrine disorders congenital adrenal hyperplasia, hypercalcemia associated with cancer, nonsuppurative thyroiditis. hydrocortisone or cortisone is the drug of choice in primary or secondary adrenocortical insufficiency.  synthetic analogs may be used in conjunction with mineralocorticoids where applicable; in infancy mineralocorticoid supplementation is of particular

Austrália - angličtina - Department of Health (Therapeutic Goods Administration)

sandoz pty ltd - calcipotriol, quantity: 52.2 microgram/g; betamethasone dipropionate, quantity: 643 microgram/g (equivalent: betamethasone, qty microgram/g) - ointment - excipient ingredients: dl-alpha-tocopherol; oleyl alcohol; liquid paraffin; white soft paraffin - indicated for the once daily topical treatment of plaque-type psoriasis vulgaris amenable to topical therapy.

Spojené štáty - angličtina - NLM (National Library of Medicine)

a-s medication solutions - betamethasone valerate (unii: 9ifa5xm7r2) (betamethasone - unii:9842x06q6m) - betamethasone 1 mg in 1 g - topical corticosteroids are indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses. topical corticosteroids are contraindicated in those patients with a history of hypersensitivity to any of the components of the preparation.

Spojené štáty - angličtina - NLM (National Library of Medicine)

a-s medication solutions - betamethasone valerate (unii: 9ifa5xm7r2) (betamethasone - unii:9842x06q6m) - betamethasone valerate 1.2 mg in 1 g - topical corticosteroids are indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses. topical corticosteroids are contraindicated in those patients with a history of hypersensitivity to any of the components of the preparation.

Spojené štáty - angličtina - NLM (National Library of Medicine)

riconpharma llc - betamethasone valerate (unii: 9ifa5xm7r2) (betamethasone - unii:9842x06q6m) - betamethasone valerate 1.2 mg in 1 g

Spojené štáty - angličtina - NLM (National Library of Medicine)

dechra veterinary products - gentamicin sulfate (unii: 8x7386qrlv) (gentamicin - unii:t6z9v48ikg), betamethasone valerate (unii: 9ifa5xm7r2) (betamethasone - unii:9842x06q6m), clotrimazole (unii: g07gz97h65) (clotrimazole - unii:g07gz97h65) - gentamicin 3 mg in 1 g - vetromax ointment is indicated for the treatment of canine acute and chronic otitis externa associated with yeast (malassezia pachydermatis, formerly pityrosporum canis) and/or bacteria susceptible to gentamicin. if hypersensitivity to any of the components occurs, treatment should be discontinued and appropriate therapy instituted. concomitant use of drugs known to induce ototoxicity should be avoided. do not use in dogs with known perforation of eardrums.

Spojené štáty - angličtina - NLM (National Library of Medicine)

clipper distributing company llc - gentamicin sulfate (unii: 8x7386qrlv) (gentamicin - unii:t6z9v48ikg), betamethasone valerate (unii: 9ifa5xm7r2) (betamethasone - unii:9842x06q6m) - gentamicin 0.57 mg in 1 ml - indications : for the treatment of infected superficial lesions in dogs caused by bacteria sensitive to gentamicin. contraindications : if hypersensitivity of any of the components occurs, treatment with this product should be discontinued and appropriate therapy instituted.

Spojené štáty - angličtina - NLM (National Library of Medicine)

henry schein animal health - gentamicin sulfate (unii: 8x7386qrlv) (gentamicin - unii:t6z9v48ikg), betamethasone valerate (unii: 9ifa5xm7r2) (betamethasone - unii:9842x06q6m) - gentamicin 0.57 mg in 1 ml - indications : for the treatment of infected superficial lesions in dogs caused by bacteria sensitive to gentamicin. contraindications : if hypersensitivity of any of the components occurs, treatment with this product should be discontinued and appropriate therapy instituted.

Spojené štáty - angličtina - NLM (National Library of Medicine)

schuyler llc - gentamicin sulfate (unii: 8x7386qrlv) (gentamicin - unii:t6z9v48ikg), betamethasone valerate (unii: 9ifa5xm7r2) (betamethasone - unii:9842x06q6m) - gentamicin 0.57 mg in 1 ml - indications : for the treatment of infected superficial lesions in dogs caused by bacteria sensitive to gentamicin. contraindications : if hypersensitivity of any of the components occurs, treatment with this product should be discontinued and appropriate therapy instituted.

Spojené štáty - angličtina - NLM (National Library of Medicine)

mwi - gentamicin sulfate (unii: 8x7386qrlv) (gentamicin - unii:t6z9v48ikg), betamethasone valerate (unii: 9ifa5xm7r2) (betamethasone - unii:9842x06q6m) - gentamicin 3 mg in 1 ml - indications: gentamicin sulfate with betamethasone valerate otic solution is indicated for the treatment of acute and chronic canine otitis externa and canine and feline superficial infected lesions caused by bacteria sensitive to gentamicin. contraindications: if hypersensitivity of any of the components occurs, treatment with this product should be discontinued and appropriate therapy instituted. concomitant use of drugs known to induce ototoxicity should be avoided. this preparation should not be used in conditions where corticosteroids are contraindicated. do not administer parenteral corticosteroids during treatment with gentamicin sulfate with betamethasone valerate otic solution.